Yokohama, Japan

Naoki Yamazaki

This inventor holds 3 USPTO granted patents. Top assignees: Meiji Seika Kabushiki Kaisha, Meiji Seika Kaburhiki Kaisha. Active years: 1992-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Yamazaki. Retrieved from https://idiyas.com/inventor/naoki-yamazaki-9ulj0t1n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1992-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Naoki Yamazaki: Innovator in Therapeutic Compositions

Introduction

Naoki Yamazaki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of therapeutic compositions, holding a total of 3 patents. His work focuses on innovative solutions for medical applications.

Latest Patents

Yamazaki's latest patents include groundbreaking inventions such as (-)-ritodrine, therapeutic compositions and use, and a method involving azole derivatives and anti-ulcerative compositions. These patents showcase his expertise in developing compounds that have potential therapeutic benefits.

Career Highlights

Throughout his career, Naoki Yamazaki has worked with notable companies, including Meiji Seika Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical sciences.

Collaborations

Yamazaki has collaborated with esteemed colleagues such as Kiyoaki Katano and Tamako Tomomoto. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Naoki Yamazaki's contributions to therapeutic compositions and his innovative patents highlight his role as a key figure in the medical research community. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…